GE HealthCare Technologies Inc. (GEHC) is the 34th largest of 300 Diagnostic Equipment companies by market capitalisation, at 30.14 Bn, behind Illumina, Inc. at 31.32 Bn. It trades on a P/E of 14.70, 51% below the peer median of 30.03. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GEHC | GE HealthCare Technologies Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 30.14 Bn | 14.70 | 1.42 | 28.03 Bn |
| 2 | LNTH | Lantheus Holdings, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.57 Bn | 23.87 | 4.22 | 5.98 Bn |
| 3 | HTFL | Heartflow, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 4.12 Bn | -169.88 | 20.31 | 3.75 Bn |
| 4 | NEOG | Neogen Corp | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 2.61 Bn | -368.79 | 3.00 | 2.43 Bn |
| 5 | BFLY | Butterfly Network, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 1.98 Bn | -26.46 | 17.66 | 1.85 Bn |
| 6 | CBLL | Ceribell, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.93 Bn | -14.05 | 9.09 | 0.80 Bn |
| 7 | QDEL | QuidelOrtho Corp | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.88 Bn | — | — | 0.76 Bn |
| 8 | VREX | Varex Imaging Corp | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.78 Bn | 34.62 | 0.90 | 0.68 Bn |
| 9 | PRE | Prenetics Global Ltd | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | -7.20 | 2.44 | 0.28 Bn |
| 10 | CV | CapsoVision, Inc | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.33 Bn | -11.87 | 22.59 | 0.32 Bn |
| 11 | NNNN | Anbio Biotechnology | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | 44.60 | 108.83 | 0.27 Bn |
| 12 | OSUR | Orasure Technologies Inc | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.24 Bn | — | 2,431.03 | 0.04 Bn |
| 13 | IMDX | Insight Molecular Diagnostics Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.79 | 90.66 | 0.13 Bn |
| 14 | HYPR | Hyperfine, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | -2.32 | 4.89 | 0.04 Bn |
| 15 | RTGN | RetinalGenix Technologies Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | — | — | 0.08 Bn |
| 16 | RPID | Rapid Micro Biosystems, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | -1.17 | 1.70 | 0.04 Bn |
| 17 | MDAI | Spectral AI, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.05 Bn | -6.01 | 3.31 | 0.04 Bn |
| 18 | NNOX | Nano-X Imaging Ltd. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.05 Bn | -0.61 | 3.31 | 0.00 Bn |
| 19 | PAVM | PAVmed Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.03 Bn | -1.13 | 243.75 | 0.03 Bn |
| 20 | QUCY | Quantum Cyber N.V. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.03 Bn | -1.05 | — | 0.01 Bn |
| 21 | AIFF | Firefly Neuroscience, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -2.32 | 12.15 | 0.01 Bn |
| 22 | PLSM | Pulsenmore Ltd. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | 8.23 | 13.89 | -0.01 Bn |
| 23 | ALRTF | ALR Technologies SG Ltd. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.55 | — | 0.01 Bn |
| 24 | ADVB | Advanced Biomed Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 2.51 | — | 0.01 Bn |
| 25 | NDRA | ENDRA Life Sciences Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -1.35 | — | 0.00 Bn |
| 26 | BMRA | Biomerica Inc | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -2.14 | 1.44 | 0.01 Bn |
| 27 | CDIO | Cardio Diagnostics Holdings, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.92 | 413.71 | 0.00 Bn |
| 28 | TRIB | Trinity Biotech Plc | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.16 | 0.13 | 0.01 Bn |
| 29 | MBAI | Check-Cap Ltd | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 1.22 | 2.72 | 0.00 Bn |
| 30 | INBS | Intelligent Bio Solutions Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.25 | 0.75 | 0.00 Bn |
| 31 | BJDX | Bluejay Diagnostics, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.28 | — | 0.00 Bn |
| 32 | ONCO | Onconetix, Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.18 | 2.85 | 0.00 Bn |
| 33 | VNRX | Volitionrx Ltd | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.09 | 0.62 | 0.00 Bn |
| 34 | VRAX | Virax Biolabs Group Ltd | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.19 | 84.17 | -0.01 Bn |
| 35 | HSCSW | HeartSciences Inc. | primary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.02 | 21.29 | 0.00 Bn |
| 36 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 647.28 Bn | 30.77 | 6.61 | 626.53 Bn |
| 37 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 442.02 Bn | 69.98 | 6.87 | 435.45 Bn |
| 38 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.57 Bn | 115.04 | 5.48 | 357.43 Bn |
| 39 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 352.77 Bn | 23.66 | 0.78 | 321.30 Bn |
| 40 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 267.21 Bn | 9.28 | 3.89 | 259.52 Bn |
| 41 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 224.87 Bn | 31.94 | 4.85 | 220.80 Bn |
| 42 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 185.16 Bn | 34.13 | 3.97 | 179.56 Bn |
| 43 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.91 Bn | -62.84 | 5.97 | 178.73 Bn |
| 44 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.97 Bn | 36.40 | 2.50 | 147.27 Bn |
| 45 | DHR | Danaher Corp /De/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 144.58 Bn | 36.24 | 5.76 | 140.23 Bn |
| 46 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.57 Bn | 30.09 | 10.53 | 124.72 Bn |
| 47 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 124.38 Bn | 39.39 | 11.27 | 119.16 Bn |
| 48 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 118.38 Bn | 22.46 | 3.15 | 109.56 Bn |
| 49 | MCK | Mckesson Corp | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 106.44 Bn | 20.08 | 0.26 | 101.27 Bn |
| 50 | BSX | Boston Scientific Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 66.75 Bn | 18.16 | 3.18 | 66.21 Bn |
| 51 | RLXXF | Relx Plc | secondary | T-23 | Business Applications | TG-03 | 62.58 Bn | — | — | 62.21 Bn |
| 52 | TEL | TE Connectivity plc | secondary | I-07 | Machinery | IG-02 | 59.56 Bn | 19.29 | 3.08 | 58.32 Bn |
| 53 | CAH | Cardinal Health Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 56.91 Bn | 33.38 | 0.22 | 52.06 Bn |
| 54 | AME | Ametek Inc/ | secondary | I-04 | Machinery | IG-02 | 54.18 Bn | 34.37 | 6.89 | 53.68 Bn |
| 55 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.50 Bn | 11.26 | 0.98 | 45.12 Bn |
| 56 | EW | Edwards Lifesciences Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 49.81 Bn | 49.63 | 7.65 | 45.55 Bn |
| 57 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.56 Bn | 52.61 | 2.13 | 48.70 Bn |
| 58 | NTRA | Natera, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 47.01 Bn | -244.49 | 17.37 | 45.91 Bn |
| 59 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.22 Bn | -25.01 | — | 44.22 Bn |
| 60 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.81 Bn | 61.51 | 2.47 | 39.16 Bn |
| 61 | VEEV | Veeva Systems Inc | secondary | T-27 | Vertical Software | TG-05 | 42.64 Bn | 42.02 | 12.33 | 35.40 Bn |
| 62 | IQV | Iqvia Holdings Inc. | secondary | H-11 | Pharma Services | HG-03 | 42.46 Bn | 32.17 | 2.50 | 40.38 Bn |
| 63 | IDXX | Idexx Laboratories Inc /De | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 41.03 Bn | 36.00 | 9.01 | 40.83 Bn |
| 64 | A | Agilent Technologies, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 40.99 Bn | 28.47 | 5.56 | 39.23 Bn |
| 65 | ROP | Roper Technologies Inc | secondary | T-19 | Business Applications | TG-03 | 39.32 Bn | 15.70 | 4.75 | 38.95 Bn |
| 66 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.00 Bn | 52.88 | 3.16 | 32.55 Bn |
| 67 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.30 Bn | 32.31 | 6.50 | 30.35 Bn |
| 68 | ILMN | Illumina, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 31.32 Bn | 37.97 | 6.97 | 30.16 Bn |
| 69 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 29.83 Bn | -20.10 | 2,731.20 | 29.83 Bn |
| 70 | MDLN | Medline Inc. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 29.46 Bn | 28.52 | 1.03 | 26.79 Bn |
| 71 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 28.11 Bn | -32.12 | 24.71 | 26.95 Bn |
| 72 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.43 Bn | 15.77 | 4.37 | 20.89 Bn |
| 73 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.96 Bn | 43.60 | 7.20 | 23.52 Bn |
| 74 | GPN | Global Payments Inc | secondary | T-54 | Fintech | TG-09 | 23.64 Bn | -24.21 | 2.31 | 18.23 Bn |
| 75 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.38 Bn | 16.31 | 6.78 | 18.72 Bn |
| 76 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.17 Bn | 26.20 | 3.51 | 20.69 Bn |
| 77 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.29 Bn | -46.96 | 1.31 | 18.40 Bn |
| 78 | SSNC | SS&C Technologies Holdings Inc | secondary | T-20 | Business Applications | TG-03 | 18.80 Bn | 22.45 | 2.86 | 18.37 Bn |
| 79 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 18.27 Bn | 21.57 | 2.15 | 17.86 Bn |
| 80 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.53 Bn | 31.57 | 5.88 | 17.41 Bn |
| 81 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.15 Bn | 32.10 | 3.97 | 16.78 Bn |
| 82 | IEX | Idex Corp /De/ | secondary | I-10 | Machinery | IG-02 | 16.74 Bn | 32.24 | 4.67 | 16.12 Bn |
| 83 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.50 Bn | 10.80 | 1.86 | 15.09 Bn |
| 84 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.48 Bn | 21.95 | 4.59 | 15.09 Bn |
| 85 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.16 Bn | 16.11 | 3.29 | 13.54 Bn |
| 86 | TU | Telus Corp | secondary | C-01 | Telecommunications | CG-01 | 14.51 Bn | -23.12 | 0.66 | 13.41 Bn |
| 87 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.48 Bn | 40.65 | 4.12 | 13.87 Bn |
| 88 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.44 Bn | 16.77 | 5.93 | 13.60 Bn |
| 89 | RVTY | Revvity, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 13.72 Bn | 57.75 | 4.71 | 12.70 Bn |
| 90 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.13 Bn | 55.67 | 3.10 | 12.99 Bn |
| 91 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.87 Bn | 559.37 | 1.16 | 10.72 Bn |
| 92 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.68 Bn | 30.66 | 7.62 | 12.45 Bn |
| 93 | PEN | Penumbra Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.59 Bn | 78.42 | 8.37 | 11.93 Bn |
| 94 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.38 Bn | 228.40 | 14.90 | 12.07 Bn |
| 95 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.90 Bn | 10.22 | 0.85 | 11.21 Bn |
| 96 | MOG-A | Moog Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 11.67 Bn | 30.96 | 2.70 | 11.61 Bn |
| 97 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.43 Bn | -38.15 | 108.87 | 10.74 Bn |
| 98 | TECH | BIO-TECHNE Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 11.27 Bn | 61.99 | 9.28 | 11.01 Bn |
| 99 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.22 Bn | -45.17 | 7.84 | 10.41 Bn |
| 100 | ALGN | Align Technology Inc | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 10.94 Bn | 26.45 | 2.64 | 9.84 Bn |
| 101 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.87 Bn | -70.72 | 14.00 | 10.55 Bn |
| 102 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.70 Bn | -67.91 | 17.46 | 10.58 Bn |
| 103 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.26 Bn | -26.91 | — | 9.50 Bn |
| 104 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.13 Bn | 18.93 | 3.22 | 9.54 Bn |
| 105 | BIO | Bio-Rad Laboratories, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 10.10 Bn | 45.42 | 3.90 | 8.48 Bn |
| 106 | HSIC | Henry Schein Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 10.06 Bn | 23.83 | 0.74 | 9.90 Bn |
| 107 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 108 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.73 Bn | -13.26 | 143.72 | 8.56 Bn |
| 109 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.67 Bn | 25.75 | 3.17 | 9.13 Bn |
| 110 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.52 Bn | -50.58 | — | 9.52 Bn |
| 111 | OSCR | Oscar Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 9.52 Bn | 17.27 | 0.62 | 0.96 Bn |
| 112 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 113 | TXG | 10x Genomics, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.64 Bn | -115.06 | 14.01 | 8.09 Bn |
| 114 | BRKR | Bruker Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.41 Bn | -78.63 | 2.40 | 8.19 Bn |
| 115 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 7.77 Bn | 21.40 | 1.97 | 7.57 Bn |
| 116 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.61 Bn | 115.01 | 4.56 | 6.95 Bn |
| 117 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 118 | OKLO | Oklo Inc. | secondary | U-03 | Power Generation | UG-01 | 7.53 Bn | -49.30 | 6,314.48 | 7.53 Bn |
| 119 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.30 Bn | 67.96 | 10.13 | 6.91 Bn |
| 120 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 7.02 Bn | 66.74 | 7.09 | 6.22 Bn |
| 121 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.43 Bn | -39.48 | 1.21 | 6.06 Bn |
| 122 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.39 Bn | -20.49 | 2.00 | 6.19 Bn |
| 123 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.30 Bn | -703.30 | 4,524.98 | 6.30 Bn |
| 124 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | -142.83 | 10.50 | 6.09 Bn |
| 125 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.16 Bn | 0.08 | — | 6.16 Bn |
| 126 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.10 Bn | 44.00 | 13.52 | 5.81 Bn |
| 127 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 6.02 Bn | 113.74 | 5.84 | 5.30 Bn |
| 128 | NCSYF | NICE Ltd. | secondary | T-26 | Workplace Software | TG-04 | 5.99 Bn | 6.47 | 1.01 | 5.63 Bn |
| 129 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.96 Bn | -5.29 | 2.65 | 5.66 Bn |
| 130 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.95 Bn | -219.40 | 31.95 | 5.64 Bn |
| 131 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.84 Bn | -33.16 | 1,162.66 | 5.66 Bn |
| 132 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.60 Bn | 35.64 | 3.92 | 5.49 Bn |
| 133 | RDNT | RadNet, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 5.55 Bn | 288.59 | 2.45 | 4.82 Bn |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.58 | 1.77 | 5.38 Bn |
| 135 | EXLS | ExlService Holdings, Inc. | secondary | T-63 | Technology Services | TG-11 | 5.36 Bn | 21.44 | 2.40 | 5.08 Bn |
| 136 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.20 Bn | 35.77 | 3.30 | 4.76 Bn |
| 137 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.02 Bn | -17.50 | — | 5.02 Bn |
| 138 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 139 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.79 Bn | 12.58 | 4.20 | 3.83 Bn |
| 140 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.67 Bn | -23.66 | — | 4.67 Bn |
| 141 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.66 Bn | 48.36 | 3.44 | 4.43 Bn |
| 142 | WAY | Waystar Holding Corp. | secondary | T-27 | Vertical Software | TG-05 | 4.52 Bn | 33.55 | 3.75 | 4.33 Bn |
| 143 | DOCS | Doximity, Inc. | secondary | T-27 | Vertical Software | TG-05 | 4.44 Bn | 26.60 | 6.78 | 3.76 Bn |
| 144 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.35 Bn | 22.97 | 2.96 | 3.84 Bn |
| 145 | ITGR | Integer Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.30 Bn | 33.48 | 2.33 | 4.28 Bn |
| 146 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.20 Bn | -11.87 | — | 4.20 Bn |
| 147 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.06 Bn | 121.75 | 1.88 | 3.76 Bn |
| 148 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | 11.43 | 3.05 | 3.84 Bn |
| 149 | MIR | Mirion Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 4.04 Bn | 157.82 | 3.94 | 3.62 Bn |
| 150 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.01 Bn | -7.85 | 1,113.28 | 4.01 Bn |
| 151 | IRTC | iRhythm Holdings, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.98 Bn | -285.33 | 4.82 | 3.39 Bn |
| 152 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.96 Bn | -45.94 | — | 3.96 Bn |
| 153 | CCC | CCC Intelligent Solutions Holdings Inc. | secondary | T-27 | Vertical Software | TG-05 | 3.93 Bn | 92.81 | 3.53 | 3.81 Bn |
| 154 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.86 Bn | -45.83 | — | 3.86 Bn |
| 155 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 156 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.80 Bn | -47.17 | 4,851.45 | 3.80 Bn |
| 157 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.72 Bn | -521.64 | 4.64 | 3.43 Bn |
| 158 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.67 Bn | -78.28 | 6.06 | 3.22 Bn |
| 159 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.26 | 0.59 | 2.48 Bn |
| 160 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.58 Bn | -7.79 | 30.61 | 2.88 Bn |
| 161 | RSMDF | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.54 Bn | 2.34 | 0.63 | 2.07 Bn |
| 162 | VCYT | Veracyte, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.49 Bn | 30.48 | 6.21 | 3.19 Bn |
| 163 | GRAL | GRAIL, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.39 Bn | -8.66 | 21.57 | 2.53 Bn |
| 164 | IPGP | Ipg Photonics Corp | secondary | I-04 | Machinery | IG-02 | 3.34 Bn | 121.17 | 3.12 | 2.47 Bn |
| 165 | OSIS | Osi Systems Inc | secondary | I-02 | Aerospace and Defense | IG-01 | 3.32 Bn | 21.45 | 1.86 | 2.96 Bn |
| 166 | SXI | Standex International Corp/De/ | secondary | I-04 | Machinery | IG-02 | 3.25 Bn | 25.28 | 3.65 | 3.07 Bn |
| 167 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.98 Bn | -11.04 | 593.06 | 2.46 Bn |
| 168 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.97 Bn | 17.34 | 4.44 | 2.50 Bn |
| 169 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.93 Bn | -8.59 | 79.75 | 2.49 Bn |
| 170 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.91 Bn | -11.22 | 408.78 | 2.91 Bn |
| 171 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -15.06 | 6.30 | 2.13 Bn |
| 172 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.72 Bn | -22.98 | 2.08 | 2.63 Bn |
| 173 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -7.52 | — | 2.63 Bn |
| 174 | CHRN | ChronoScale Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.63 Bn | -55.84 | 41.09 | 2.62 Bn |
| 175 | WGS | GeneDx Holdings Corp. | secondary | H-17 | Healthcare Providers | HG-04 | 2.63 Bn | -24.71 | 5.78 | 2.50 Bn |
| 176 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -80.89 | — | 2.63 Bn |
| 177 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 4.56 | 0.06 | -3.18 Bn |
| 178 | CDNA | CareDx, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 2.61 Bn | 23.49 | 5.69 | 2.23 Bn |
| 179 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | -61.76 | — | 2.61 Bn |
| 180 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.60 Bn | 246.56 | 4.57 | 2.43 Bn |
| 181 | PRVA | Privia Health Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.58 Bn | 76.26 | 1.09 | 2.17 Bn |
| 182 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.54 Bn | -171.63 | 10.11 | 2.43 Bn |
| 183 | LIFE | Ethos Technologies Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 2.52 Bn | -20.68 | 4.45 | 2.35 Bn |
| 184 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 185 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.62 | 3.09 | 2.06 Bn |
| 186 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | 13.65 | 2.54 | 1.63 Bn |
| 187 | HURN | Huron Consulting Group Inc. | secondary | I-26 | Business Services | IG-06 | 2.39 Bn | 20.70 | 1.70 | 2.36 Bn |
| 188 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.39 Bn | -2.19 | 0.22 | 0.55 Bn |
| 189 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -5.98 | 4.30 | 1.95 Bn |
| 190 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -21.17 | 13.48 | 2.29 Bn |
| 191 | CLOV | Clover Health Investments, Corp. /De | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.23 Bn | -121.62 | 0.90 | 1.99 Bn |
| 192 | ESTA | Establishment Labs Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.23 Bn | -57.32 | 9.07 | 2.16 Bn |
| 193 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.22 Bn | -3.79 | — | 1.95 Bn |
| 194 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.20 Bn | -41.43 | — | 1.88 Bn |
| 195 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.17 Bn | 30.03 | 3.44 | 2.16 Bn |
| 196 | XRAY | DENTSPLY SIRONA Inc. | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 2.16 Bn | -3.95 | 0.59 | 1.92 Bn |
| 197 | FLYW | Flywire Corp | secondary | T-54 | Fintech | TG-09 | 2.14 Bn | 63.01 | 3.01 | 1.85 Bn |
| 198 | PGNY | Progyny, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.12 Bn | 26.97 | 1.62 | 1.88 Bn |
| 199 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.68 | 6.74 | 1.66 Bn |
| 200 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.04 Bn | -4.91 | 2,043.58 | 2.04 Bn |
| 201 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.99 Bn | 79.20 | 6.49 | 1.82 Bn |
| 202 | NVCR | NovoCure Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.91 Bn | -12.87 | 2.73 | 1.47 Bn |
| 203 | INSP | Inspire Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.91 Bn | 14.15 | 2.13 | 1.59 Bn |
| 204 | EPAC | Enerpac Tool Group Corp | secondary | I-08 | Machinery | IG-02 | 1.89 Bn | 20.21 | 2.97 | 1.77 Bn |
| 205 | INOD | Innodata Inc | secondary | T-63 | Technology Services | TG-11 | 1.85 Bn | 31.60 | 5.82 | 1.60 Bn |
| 206 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.82 Bn | 27.65 | 6.92 | 1.44 Bn |
| 207 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.73 Bn | 29.80 | 16.79 | 1.64 Bn |
| 208 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.66 Bn | -9.11 | 20.12 | 1.38 Bn |
| 209 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.65 Bn | 172.59 | 16.44 | 1.62 Bn |
| 210 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.92 | 3.02 | 0.98 Bn |
| 211 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.52 Bn | 38.88 | 1.22 | 1.23 Bn |
| 212 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.25 | 2.09 | 1.21 Bn |
| 213 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | 13.88 | 1.53 | 1.14 Bn |
| 214 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.47 Bn | -13.34 | 1.80 | 1.35 Bn |
| 215 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -85.23 | 4.36 | 1.34 Bn |
| 216 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.45 Bn | -23.93 | — | 1.45 Bn |
| 217 | SDGR | Schrodinger, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.45 Bn | -26.61 | 5.58 | 1.03 Bn |
| 218 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -42.36 | 5.14 | 1.33 Bn |
| 219 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.41 Bn | 24.99 | 1.03 | 1.37 Bn |
| 220 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -8.62 | — | 1.41 Bn |
| 221 | ABSI | Absci Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | -11.43 | 886.72 | 1.18 Bn |
| 222 | AZTA | Azenta, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.38 Bn | -4.40 | 1.31 | 1.06 Bn |
| 223 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.63 | 35.82 | 1.38 Bn |
| 224 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.36 Bn | -10.30 | 14.25 | 1.00 Bn |
| 225 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.34 Bn | -21.12 | 1.28 | 0.88 Bn |
| 226 | AFYA | Afya Ltd | secondary | D-28 | Consumer Services | DG-09 | 1.27 Bn | 5.61 | 1.19 | 1.07 Bn |
| 227 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -171.60 | 0.75 | 0.97 Bn |
| 228 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -390.63 | 2.62 | 1.16 Bn |
| 229 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -28.18 | 3.12 | 1.12 Bn |
| 230 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -25.51 | — | 1.00 Bn |
| 231 | EVCM | EverCommerce Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.21 Bn | 35.58 | 2.02 | 1.08 Bn |
| 232 | STAA | Staar Surgical Co | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | 61.80 | 3.51 | 1.01 Bn |
| 233 | CLVT | Clarivate Plc | secondary | T-22 | Business Applications | TG-03 | 1.19 Bn | -3.57 | 0.49 | 0.97 Bn |
| 234 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | -10.41 | 3.53 | 0.92 Bn |
| 235 | ASST | Strive, Inc. | secondary | F-09 | Asset and Wealth Management | FG-03 | 1.19 Bn | -3.00 | 4,564.11 | 1.12 Bn |
| 236 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -31.20 | 2.01 | 0.88 Bn |
| 237 | THRM | Gentherm Inc | secondary | I-04 | Machinery | IG-02 | 1.17 Bn | 10.84 | 0.74 | 0.96 Bn |
| 238 | DRTS | Alpha Tau Medical Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | 12.71 | — | 1.07 Bn |
| 239 | CERT | Certara, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.17 Bn | -17.07 | 2.86 | 0.98 Bn |
| 240 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 241 | GDRX | GoodRx Holdings, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.17 Bn | 71.72 | 1.48 | 0.87 Bn |
| 242 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.11 Bn | -5.44 | — | 1.11 Bn |
| 243 | TDOC | Teladoc Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 1.10 Bn | -6.20 | 0.44 | 0.33 Bn |
| 244 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.09 Bn | -4.56 | 14.07 | 1.09 Bn |
| 245 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.07 Bn | 46.60 | 12.40 | 1.01 Bn |
| 246 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 68.97 | 1.35 | 0.76 Bn |
| 247 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.30 | — | 0.92 Bn |
| 248 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.19 | 2.57 | 0.48 Bn |
| 249 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -15.17 | 23.01 | 0.76 Bn |
| 250 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.76 | — | 0.74 Bn |
| 251 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.94 Bn | 15.24 | 1.61 | 0.91 Bn |
| 252 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -48.72 | — | 0.93 Bn |
| 253 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.85 Bn | -11.62 | 7.13 | 0.67 Bn |
| 254 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -57.28 | 3.91 | 0.69 Bn |
| 255 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.83 Bn | -10.47 | 101.42 | 0.83 Bn |
| 256 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.83 Bn | -10.02 | 371.65 | 0.83 Bn |
| 257 | HSTM | Healthstream Inc | secondary | T-27 | Vertical Software | TG-05 | 0.83 Bn | 39.12 | 2.58 | 0.76 Bn |
| 258 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.81 Bn | -7.02 | 9.24 | 0.67 Bn |
| 259 | AHCO | AdaptHealth Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 0.78 Bn | -3.48 | 0.24 | 0.73 Bn |
| 260 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | 16.04 | 0.95 | 0.62 Bn |
| 261 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | -7.62 | 3.12 | 0.56 Bn |
| 262 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | 12.52 | 5.36 | 0.51 Bn |
| 263 | PAYS | Paysign, Inc. | secondary | T-54 | Fintech | TG-09 | 0.72 Bn | 45.69 | 7.16 | 0.54 Bn |
| 264 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | -38.47 | 5.95 | 0.65 Bn |
| 265 | MLAB | Mesa Laboratories Inc /Co/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.71 Bn | 200.71 | 2.83 | 0.67 Bn |
| 266 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 267 | CCSI | Consensus Cloud Solutions, Inc. | secondary | T-26 | Workplace Software | TG-04 | 0.66 Bn | 7.00 | 1.87 | 0.56 Bn |
| 268 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.65 Bn | -42.55 | 12.45 | 0.63 Bn |
| 269 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.10 | 1.71 | 0.38 Bn |
| 270 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.17 | 11.82 | 0.54 Bn |
| 271 | PHR | Phreesia, Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.64 Bn | 61.01 | 1.26 | 0.64 Bn |
| 272 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.63 Bn | -17.20 | 1.97 | 0.58 Bn |
| 273 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -3.07 | — | 0.62 Bn |
| 274 | CTEV | Claritev Corp | secondary | T-27 | Vertical Software | TG-05 | 0.61 Bn | -2.17 | 0.62 | 0.59 Bn |
| 275 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -347,652.42 | — | 0.61 Bn |
| 276 | CTKB | Cytek Biosciences, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.60 Bn | -7.41 | 2.89 | 0.52 Bn |
| 277 | BRSYF | Brainsway Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 60.53 | 9.76 | 0.53 Bn |
| 278 | WEAV | Weave Communications, Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.58 Bn | -28.29 | 2.26 | 0.54 Bn |
| 279 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,177.02 | 6.09 | 0.49 Bn |
| 280 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.58 Bn | -16.78 | 1.82 | 0.53 Bn |
| 281 | FLGT | Fulgent Genetics, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.56 Bn | -6.59 | 2.31 | 0.30 Bn |
| 282 | SOPH | SOPHiA GENETICS SA | secondary | T-27 | Vertical Software | TG-05 | 0.55 Bn | -6.77 | 6.35 | 0.44 Bn |
| 283 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -18.00 | — | 0.54 Bn |
| 284 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -15.54 | 338.65 | 0.42 Bn |
| 285 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -5.46 | 53.86 | 0.44 Bn |
| 286 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -2.39 | 4.53 | 0.39 Bn |
| 287 | KIDS | Orthopediatrics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.53 Bn | -13.30 | 2.09 | 0.48 Bn |
| 288 | SENS | Senseonics Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.53 Bn | -4.82 | 10.85 | 0.29 Bn |
| 289 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -11.65 | 13.41 | 0.46 Bn |
| 290 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -7.62 | 22.90 | 0.23 Bn |
| 291 | CERS | Cerus Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | -27.93 | 2.02 | 0.45 Bn |
| 292 | NPCE | NeuroPace Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | -26.20 | 5.03 | 0.45 Bn |
| 293 | TCMD | Tactile Systems Technology Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.49 Bn | 19.95 | 1.41 | 0.41 Bn |
| 294 | DDD | 3D Systems Corp | secondary | I-12 | Machinery | IG-02 | 0.49 Bn | -9.76 | 1.27 | 0.36 Bn |
| 295 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.49 Bn | -10.27 | 78.36 | 0.26 Bn |
| 296 | EVH | Evolent Health, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.47 Bn | -0.93 | 0.23 | 0.33 Bn |
| 297 | NRC | Nrc Health | secondary | T-27 | Vertical Software | TG-05 | 0.46 Bn | 79.07 | 3.31 | 0.46 Bn |
| 298 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -12.64 | 892.03 | 0.32 Bn |
| 299 | MTLS | Materialise Nv | secondary | T-20 | Business Applications | TG-03 | 0.45 Bn | 28.98 | 1.40 | 0.45 Bn |
| 300 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.94 | 28.10 | 0.25 Bn |